SCHEMBL9275073

SCHEMBL9275073

CCS(=O)(=O)Cc1ccc2[nH]ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.47
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP2A6 P11509 2/20 0.42
▸ AHR P35869 3/20 0.42
▸ NR4A2 P43354 2/20 0.42
▸ F7 P08709 1/20 0.42
▸ LTA4H P09960 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ RAD51 Q06609 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8990514 0.85 EPHX2 (0.53) CYP19A1CA12CA1CA2CA9
SCHEMBL1650589 0.81 CA1 (0.51) CYP19A1CA12CA1CA2CA9
SCHEMBL30155019 0.81 CA1 (0.51) CYP19A1CA12CA1CA2CA9
SCHEMBL5918472 0.81 CYP19A1 (0.55) CYP19A1CA12CA1CA2CA9
SCHEMBL29445647 0.78 AHR (0.50) HDAC1HDAC8MAPTCYP2A6AHR
SCHEMBL763201 0.78 AHR (0.50) HDAC1HDAC8MAPTCYP2A6AHR
Sulfuric Acid SCHEMBL1491064 0.78 CA1 (0.48) CYP19A1CA12CA1CA2CA9
Sulfuric Acid SCHEMBL9705330 0.77 CYP19A1 (0.51) CYP19A1HDAC1HDAC8KDM4EMAPT
SCHEMBL9371107 0.76 CYP19A1 (0.50) CYP19A1HDAC1HDAC8MAPTMAOA
SCHEMBL28853829 0.75 PTGS2 (0.53) CYP19A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666258-A1 Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents Bristol-Myers Squibb Company (US) 1995-08-09 — — EP disclosed
Send feedback